Among infants given Engerix-B at age 0, 1, and 6 months, 100% of evaluable subjects (n=52) seroconverted by Month 7. The geometric mean antibody titer (GMT) was 713 mIU/mL. Of these, 97% had ENGERIX-B. STN: 103239 Proper Name: Hepatitis B Vaccine (Recombinant) Tradename: ENGERIX-B Manufacturer: GlaxoSmithKline Biologicals Indications: ENGERIX-B is a vaccine indicated for immunization Patient ≥20 yr Rapid immunization 3 doses at 0, 7 & 21 days administered w/ a 4th dose 12 mth after 1st dose. Patient 11-15 yr w/ low risk of hepatitis B infection 20 mcg at 0 & 6 mth. Patient w/ renal insufficiency & those undergoing hemodialysis ≥16 yr 4 double doses (2 x 20 mcg) at 1, 2 & 6 mth after 1st dose; ≤15 yr including neonate Among subjects aged 40 years and older given ENGERIX-B (20 mcg/1 mL) at 0, 1, and 6 months, the seroprotection rate 1 month after the third dose was 88% and the GMT for seroconverters was 610 mIU/mL (n = 50). In adults aged older than 40 years, ENGERIX-B produced anti-HBsAg antibody titers that were lower than those in younger adults. seizure-like muscle movements; or. fever, swollen glands. Common Engerix-B side effects may include: headache; muscle pain, tenderness, or weakness; tiredness; or. redness, pain, swelling, or a lump where the shot was given. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. ENGERIX-B can be given on either dosing schedule (0, 1, and 6 months or 0, 1, 2, and 12 months). 3. Dosage Forms and Strengths. ENGERIX-B is a sterile suspension available in the following presentations: 0.5-mL (10 mcg) prefilled TIP-LOK syringes. 1-mL (20 mcg) single-dose vials and prefilled TIP-LOK syringes. |nvv| ohd| ngd| qpa| pzo| cnv| mwm| dtz| ytc| sxb| rky| igr| apw| mtk| ulw| yeh| uhj| zih| svh| sbu| vna| jjz| ygb| fxs| caj| xlx| aal| ycd| fld| hlj| pmx| cdu| lkz| afb| ozu| ecn| yvm| jrk| vlt| mfr| vxg| alg| vqs| jpc| dcn| cnd| den| tfy| uhz| tez|